enkephalinamide-met, ala(2)- has been researched along with Disease Models, Animal in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Schneider, JS; Schroeder, JA | 1 |
Peets, JM; Pomeranz, B; Power, C | 1 |
2 other study(ies) available for enkephalinamide-met, ala(2)- and Disease Models, Animal
Article | Year |
---|---|
GABA-opioid interactions in the globus pallidus: [D-Ala2]-Met-enkephalinamide attenuates potassium-evoked GABA release after nigrostriatal lesion.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Behavior, Animal; Cats; Disease Models, Animal; Enkephalin, Methionine; Extracellular Space; gamma-Aminobutyric Acid; Globus Pallidus; Male; Microdialysis; Naloxone; Narcotic Antagonists; Parkinsonian Disorders; Potassium; Recovery of Function | 2002 |
Long latency spinal cord dorsum potential; suppression by intrathecal morphine and enkephalin analog.
Topics: Analgesics; Animals; Disease Models, Animal; Drug Evaluation, Preclinical; Enkephalin, Methionine; Evoked Potentials; Injections, Spinal; Male; Morphine; Pain; Rats; Rats, Inbred Strains; Spinal Cord | 1984 |